This is the first report on the long-term durability of response among complete responders to mitomycin C chemoablation of low-grade upper tract urothelial carcinoma.

More people are turning to testosterone replacement therapy. In fact, it’s estimated that prescriptions for the treatment ...

In 2024, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common cause of hair ...

The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first popularized in the ...

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be ...

The drug, YCT-529, is being development by ... designed to suppress sperm production while maintaining healthy testosterone levels. The gel is currently in clinical trials being conducted ...

Medically reviewed by Matthew Wosnitzer, MD Erectile dysfunction (ED) is an inability to achieve or maintain an erection during sex or with sexual stimulation. It can affect people at any age but ...

Endo shareholders will get $80 million in cash and own 49.9 per cent of the combined company, while Mallinckrodt shareholders will own the rest for an enterprise value of $6.7 billion ...

After being assessed, he started on a low dose of TRT gel in December to improve low testosterone. But while Illman was prescribed the therapy, a London urologist says some men are taking it ...

After being assessed, he started on a low dose of TRT gel in December to improve low testosterone. But while Illman was prescribed the therapy, a London urologist says some men are taking it without ...